On and effective June 1, 2022, Debra Peattie, PhD, MBA gave notice to Inhibitor Therapeutics, Inc. (the “Company”) of her retirement from the Board of Directors of the Company (the “Board”). The purpose of Dr. Peattie's retirement is to focus on other professional opportunities and not based on any disagreement with the Company on any matter relating to the Company's operations, policies or practices.